MRI Characteristics of Ependymoblastoma: Results from 22 Centrally Reviewed Cases

REFERENCES

1. 1.↵
   2. Louis DN,
   3. Ohgaki H,
   4. Wiestler OD, et al

   . WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2007

   Google Scholar
2. 2.↵
   2. Osborn AG

   . Osborn's Brain: Imaging, Pathology, and Anatomy. Salt Lake City: Amirsys; 2013:573–75

   Google Scholar
3. 3.↵
   2. Gerber NU,
   3. von Hoff K,
   4. von Bueren AO, et al

   . Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. J Neurooncol 2011;102:459–69

   CrossRefPubMedGoogle Scholar
4. 4.↵
   2. Morovic A,
   3. Damjanov I

   . Neuroectodermal ovarian tumors: a brief overview. Histol Histopathol 2008;23:765–71

   PubMedGoogle Scholar
5. 5.↵
   2. Santi M,
   3. Bulas D,
   4. Fasano R, et al

   . Congenital ependymoblastoma arising in the sacrococcygeal soft tissue: a case study. Clin Neuropathol 2008;27:78–82

   CrossRefPubMedGoogle Scholar
6. 6.↵
   2. Bailey P,
   3. Cushing H

   . A Classification of the Tumors of the Glioma Group on a Histogenetic Basis With a Correlated Study of Prognosis. Philadelphia: JB Lippincott Co.; 1926

   Google Scholar
7. 7.↵
   2. Judkins AR,
   3. Ellison DW

   . Ependymoblastoma: dear, damned, distracting diagnosis, farewell!*. Brain Pathol 2010;20:133–39

   CrossRefPubMedWeb of ScienceGoogle Scholar
8. 8.↵
   2. Rubinstein LJ

   . The definition of the ependymoblastoma. Arch Pathol 1970;90:35–45

   PubMedWeb of ScienceGoogle Scholar
9. 9.↵
   2. Rutkowski S,
   3. von Bueren A,
   4. von Hoff K, et al

   . Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91. Clin Cancer Res 2007;13:2651–57

   Abstract/FREE Full TextGoogle Scholar
10. 10.↵
    2. von Hoff K,
    3. Hinkes B,
    4. Gerber NU, et al

    . Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer 2009;45:1209–17

    CrossRefPubMedWeb of ScienceGoogle Scholar
11. 11.↵
    2. Friedrich C,
    3. von Bueren AO,
    4. von Hoff K, et al

    . Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol 2013;15:224–34

    Abstract/FREE Full TextGoogle Scholar
12. 12.↵
    2. Korshunov A,
    3. Sturm D,
    4. Ryzhova M, et al

    . Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 2014;128:279–89

    CrossRefPubMedWeb of ScienceGoogle Scholar
13. 13.↵
    2. Laurent JP,
    3. Chang CH,
    4. Cohen ME

    . A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Cancer 1985;56:1807–09

    CrossRefPubMedGoogle Scholar
14. 14.↵
    2. Nowak J,
    3. Seidel C,
    4. Pietsch T, et al

    . Ependymoblastoma of the brainstem: MRI findings and differential diagnosis. Pediatr Blood Cancer 2014;61:1132–34

    CrossRefPubMedGoogle Scholar
15. 15.↵
    German Childhood Cancer Registry. Annual Report 2011. http://www.kinderkrebsregister.de/fileadmin/kliniken/dkkr/pdf/jb/jb2010/jb2010_2_Diagnosen.pdf. Accessed March 3, 2014.

    Google Scholar
16. 16.↵
    2. Smoll NR,
    3. Drummond KJ

    . The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children. J Clin Neurosci 2012;19:1541–44

    CrossRefPubMedGoogle Scholar
17. 17.↵
    2. Cervoni L,
    3. Celli P,
    4. Trillo G, et al

    . Ependymoblastoma: a clinical review. Neurosurg Rev 1995;18:189–92

    CrossRefPubMedWeb of ScienceGoogle Scholar
18. 18.↵
    2. Dorsay TA,
    3. Rovira MJ,
    4. Ho VB, et al

    . Ependymoblastoma: MR presentation. A case report and review of the literature. Pediatr Radiol 1995;25:433–35

    CrossRefPubMedGoogle Scholar
19. 19.↵
    2. Nejat F,
    3. Kazmi SS,
    4. Ardakani SB

    . Congenital brain tumors in a series of seven patients. Pediatr Neurosurg 2008;44:1–8

    CrossRefPubMedWeb of ScienceGoogle Scholar
20. 20.↵
    2. Ng SH,
    3. Ko SF,
    4. Chen YL, et al

    . Ependymoblastoma: CT and MRI demonstration. Chin J Radiol 2002;27:21–25

    Google Scholar
21. 21.↵
    2. Ortiz J,
    3. Otero A,
    4. Bengoechea O, et al

    . Divergent ependymal tumor (ependymoblastoma/anaplastic ependymoma) of the posterior fossa: an uncommon case observed in a child. J Child Neurol 2008;23:1058–61

    Abstract/FREE Full TextGoogle Scholar
22. 22.↵
    2. Chawla A,
    3. Emmanuel JV,
    4. Seow WT, et al

    . Paediatric PNET: pre-surgical MRI features. Clin Radiol 2007;62:43–52

    CrossRefPubMedGoogle Scholar
23. 23.↵
    2. Newton H,
    3. Jolesz F

    . Handbook of Neuro-Oncology Neuroimaging. New York: Elsevier; 2008

    Google Scholar
24. 24.↵
    2. Gauvain KM,
    3. McKinstry RC,
    4. Mukherjee P, et al

    . Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. AJR Am J Roentgenol 2001;177:449–54

    CrossRefPubMedWeb of ScienceGoogle Scholar
25. 25.↵
    2. Poussaint TY

    . Magnetic resonance imaging of pediatric brain tumors: state of the art. Top Magn Reson Imaging 2001;12:411–33

    CrossRefPubMedGoogle Scholar
26. 26.↵
    2. Borja MJ,
    3. Plaza MJ,
    4. Altman N, et al

    . Conventional and advanced MRI features of pediatric intracranial tumors: supratentorial tumors. AJR Am J Roentgenol 2013;200:W483–503

    CrossRefPubMedGoogle Scholar
27. 27.↵
    2. Kovanlikaya A,
    3. Panigrahy A,
    4. Krieger MD, et al

    . Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. Radiology 2005;236:1020–25

    CrossRefPubMedGoogle Scholar
28. 28.↵
    2. Law M,
    3. Kazmi K,
    4. Wetzel S, et al

    . Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors. AJNR Am J Neuroradiol 2004;25:997–1005

    Abstract/FREE Full TextGoogle Scholar
29. 29.↵
    2. Hua C,
    3. Merchant TE,
    4. Gajjar A, et al

    . Brain tumor therapy-induced changes in normal-appearing brainstem measured with longitudinal diffusion tensor imaging. Int J Radiat Oncol Biol Phys 2012;82:2047–54

    CrossRefPubMedGoogle Scholar
30. 30.↵
    2. Godfraind C

    . Classification and controversies in pathology of ependymomas. Childs Nerv Syst 2009;25:1185–93

    CrossRefPubMedWeb of ScienceGoogle Scholar
31. 31.↵
    2. Eberhart CG,
    3. Brat DJ,
    4. Cohen KJ, et al

    . Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol 2000;3:346–52

    CrossRefPubMedGoogle Scholar
32. 32.↵
    2. Gessi M,
    3. Giangaspero F,
    4. Lauriola L, et al

    . Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol 2009;33:211–17

    CrossRefPubMedWeb of ScienceGoogle Scholar
33. 33.↵
    2. Korshunov A,
    3. Remke M,
    4. Gessi M, et al

    . Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes. Acta Neuropathol 2010;120:253–60

    CrossRefPubMedWeb of ScienceGoogle Scholar
34. 34.↵
    2. Ceccom J,
    3. Bourdeaut F,
    4. Loukh N, et al

    . Embryonal tumor with multilayered rosettes: diagnostic tools update and review of the literature. Clin Neuropathol 2014;33:15–22

    CrossRefPubMedGoogle Scholar